RARRES2 and cancer: Altered levels of chemerin and the cognate receptors, chemerin1, chemerin2, and CCRL2 have also been identified in several cancer types and many of the fundamental biological activities (e.g., chemotaxis, proliferation, differentiation) of chemerin have the potential to affect tumorigenesis and tumor progression.